Is CelLBxHealth plc (AGL.L) a Buy, Sell, or Hold?
LSE : AGL.L
CelLBxHealth plc
$0.92 GBp
-$0.06 (-5.64%)
- Volume
- 4.29K
- Average Volume
- 2.39M
- Market Capitalization
- $2.97M
- P/E Ratio
- -0.24
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $17.45
- Year Low
- $0.85
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.76
Company Overview
LSE
Peter Michael Collins
Medical - Distribution
Healthcare
AGL.L
119
GB
GBp
Liquidity Metrics
0.25
2.76
2.41
1.95
0.00
Sales & Valuation
$1.35M
2.20
1.45
-0.31
-0.01
Profitability
-$0.0551
-$19.51M
-1444.04%
-1796.74%
-191.36%
-155.03%
P/E Metrics
-0.24
-0.01
-0.01
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-21.98
2/9
$6.62M
$12.58M
$5.39M
-$23.6M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Andrew David William Newland | Founder, Chief Executive Officer & Executive Director |
| Karen Miller | Chief Scientific Officer |
| Andrew John Holder | Head of Investor Relations |
| Brett Swansiger | Chief Commercial Officer |
| Ian Francis Griffiths | Chief Financial Officer, Finance Director, Company Secretary & Executive Director |
| Anne-Sophie Pailhes-Jimenez | Head of R&D and Senior Director |
| Michelle Munson | Human Resources Director |
Poll Results
No votes yet today — be the first to share your view!
About CelLBxHealth plc (LSE:AGL.L) Stock
CelLBxHealth Plc is a holding company, which engages in the provision of its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom. ...
Frequently Asked Questions
-
What is the current CelLBxHealth plc (AGL.L) stock price?
-
CelLBxHealth plc(LSE:AGL.L) stock price is $0.92 in the last trading session. During the trading session, AGL.L stock reached the peak price of $17.445 while $0.85 was the lowest point it dropped to. The percentage change in AGL.L stock occurred in the recent session was --5.64% while the dollar amount for the price change in AGL.L stock was -$0.06.
-
AGL.L's industry and sector of operation?
-
The LSE listed AGL.L is part of Medical - Distribution industry that operates in the broader Healthcare sector.
-
Who are the executives of AGL.L?
-
Andrew David William Newland | Founder, Chief Executive Officer & Executive Director
Karen Miller | Chief Scientific Officer
Andrew John Holder | Head of Investor Relations
Brett Swansiger | Chief Commercial Officer
Ian Francis Griffiths | Chief Financial Officer, Finance Director, Company Secretary & Executive Director -
How many employees does AGL.L have?
-
Number of AGL.L employees currently stands at 119. AGL.L operates from 4th Floor, Reading Bridge House, George Street, Guildford, None RG1 8LS, GB.
-
Link for AGL.L official website?
-
Official Website of AGL.L is: http://www.angleplc.com
-
How do I contact AGL.L?
-
AGL.L could be contacted at phone #44 14 8334 3434 and can also be accessed through its website. AGL.L operates from 4th Floor, Reading Bridge House, George Street, Guildford, None RG1 8LS, GB.
-
How many shares of AGL.L are traded daily?
-
The average number of AGL.L shares traded daily for last 3 months was 2.39M.
-
What is the market cap of AGL.L currently?
-
The market value of AGL.L currently stands at $2.97M with its latest stock price at $0.92